Mega Medtech M&A Momentum In 2015

Medtech M&A activity has been on the rise for several years along with a surge in the number of higher-valued mega-deals, those worth at least $1 billion. Yet a survey of all deals with known values indicates that median deal value has actually declined.

Medtech M&A activity has been on the rise for several years and shows no signs of slowing down. The industry has seen its deals getting bigger and bigger, giving way to a surge in the number of higher-valued mega-deals, or those worth at least $1 billion. For each of the past two years there have been at least 10 mega-mergers, three of which were over $10 billion.

While the exact drivers behind these mega M&As vary for each transaction, there are some common factors inexorably contributing to...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Deal-Making

More from In Vivo